The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Hims & Hers Health Inc (NYSE: HIMS) closed at $56.77 in the last session, up 0.37% from day before closing price of $56.56. In other words, the price has increased by $0.37 from its previous closing price. On the day, 35.74 million shares were traded.
Ratios:
We take a closer look at HIMS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 39.38 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 54.01. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.59. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On February 18, 2025, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also upped its target price recommendation from $42 to $60.
Citigroup Downgraded its Neutral to Sell on January 10, 2025, whereas the target price for the stock was revised from $24 to $25.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 28 ’25 when Okupe Oluyemi sold 11,581 shares for $52.98 per share. The transaction valued at 613,537 led to the insider holds 39,153 shares of the business.
Boughton Soleil sold 3,233 shares of HIMS for $180,628 on May 27 ’25. The Chief Legal Officer now owns 153,194 shares after completing the transaction at $55.87 per share. On May 22 ’25, another insider, Becklund Irene, who serves as the PAO of the company, sold 5,071 shares for $53.51 each. As a result, the insider received 271,349 and left with 0 shares of the company.
Valuation Measures:
As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 82.63, and their Forward P/E ratio for the next fiscal year is 59.49. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.39. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.12 while its Price-to-Book (P/B) ratio in mrq is 23.11.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $13.47. The 50-Day Moving Average of the stock is 40.56%, while the 200-Day Moving Average is calculated to be 85.36%.
Shares Statistics:
A total of 215.21M shares are outstanding, with a floating share count of 200.63M. Insiders hold about 10.37% of the company’s shares, while institutions hold 70.36% stake in the company.
